Kriya Therapeutics
Latest round
- Series D
Last raised
- Jul 2025
Total raised
- $860M
Investors
- 16
About Kriya Therapeutics
Founded in 2019 and based in California, US, Kriya Therapeutics, Inc. operates as a biotechnology company that focuses on the treatment of diabetes and obesity. The company was co-founded by Shankar Ramaswamy (CEO), Roger Jeffs (Vice-Chairman), and Dr. Fraser Wright (Chief Scientific Advisor). In July 2025, Kriya Therapeutics, Inc. In September 2025, Kriya Therapeutics, Inc. The company aims to design, develop, and manufacture gene therapies. Kriya is built on two distinct technology platforms: its computationally enabled proprietary platform for rational vector design (SIRVE) and its manufacturing platform for production (STRIPE). The company is advancing a deep and diversified pipeline of innovative gene therapies spanning rare and prevalent diseases in multiple therapeutic verticals, with current pipeline programs addressing metabolic, ophthalmic, and oncologic diseases.
Who invested in Kriya Therapeutics
16 investors across 6 rounds
See all investors in Kriya Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kriya Therapeutics
Who invested in Kriya Therapeutics?
Kriya Therapeutics has 16 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kriya Therapeutics raised?
Kriya Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Kriya Therapeutics last raise money?
Kriya Therapeutics's most recent round on record is a Series D, in Jul 2025.
What does Kriya Therapeutics do?
Founded in 2019 and based in California, US, Kriya Therapeutics, Inc.
Where is Kriya Therapeutics headquartered?
Kriya Therapeutics is headquartered in Palo Alto, US.
Which VCs invest in companies like Kriya Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kriya Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Kriya Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.